Clinical Trials Browser

Phase 2 × Atovaquone × 1 year × Clear all

NCT05998135 2025-09-11

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Phase 2 Recruiting

Ovarian High Grade Serous Adenocarcinoma